Quoin Pharmaceuticals, Ltd. Research And Development Expense

• Quoin Pharmaceuticals, Ltd. showed an increase of +172.1% in Research And Development Expense from 2024 to 2025.
• This data is from Quoin Pharmaceuticals, Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 11 years of available data (2015 to 2025), Quoin Pharmaceuticals, Ltd.'s Research And Development Expense has grown by 66.3%.
• Historical annual values: Fiscal year 2025: $9.80 million | Fiscal year 2024: $3.60 million | Fiscal year 2023: $3.31 million | Fiscal year 2022: $2.67 million | Fiscal year 2021: $1.56 million | Fiscal year 2020: $244.2 thousand | Fiscal year 2019: $45.7 thousand | Fiscal year 2018: $13.51 million | Fiscal year 2017: -$11.50 million | Fiscal year 2016: $8.26 million | Fiscal year 2015: $5.89 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026